Lupus nephritis drug completes successful clinical trials
An experimental drug used to treat patients with lupus nephritis has successfully completed clinical trials and its maker will seek approval from the U.S. Food and Drug Administration in 2020. If approved, it would be the first drug approved to specifically treat lupus nephritis. READ MORE >>
TOPICS: Research